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Abstract
Background: Ischemic stroke is the third leading cause of death in adults worldwide and is the first leading cause
of long-term disability. Neurogenesis plays an important role in promoting behavioral recovery after stroke. Huatuo
Zaizao pill (HT), a traditional Chinese medicine, has been used clinically in China to promote the rehabilitation after
stroke, but the underlying mechanism of action was still unclear. This study is to investigate the effects of HT on the
functional recovery in a rat model of cerebral ischemia-reperfusion (I/R) injury, and the potential molecular mechanisms.
Methods: Rats were randomly divided into sham, model with cerebral I/R injury, or HT-treated groups, then
administered orally with vehicle (for the sham and model group) or HT (0.5, 1.0, or 2.0 mg/kg) respectively,
for 3 or 7 days. Functional recovery was assessed by cylinder test, beam walking test, and adhesive test.
Neurogenesis was investigated by double immunofluorescence staining for 5-ethynyl-2-deoxyuridine (EdU)
and neuronal nuclear protein (NeuN). The proteins of kinase A (PKA), cAMP response element-binding protein
(CREB), and brain-derived neurotrophic factor (BDNF) were assayed by western blotting. The level of BDNF
mRNA was evaluated by RT-PCR.
Results: Compared with the model group, treatment with HT significantly promoted functional recovery in I/R
injured rats (p < 0.05 or p < 0.01). The generation of new neurons was increased in the HT groups. HT treatment for
3 days increased the level of BDNF mRNA in I/R injured rats. Expression of PKA, phosphorylated CREB, and BDNF were
significantly (p < 0.05) increased with the 7-day HT treatment.
Conclusions: These results indicated that HT treatment could promote functional recovery after stroke. HT enhanced
the expression of BDNF and increased the level of neurogenesis in cerebral I/R animal, which might be associated with
the functional recovery.
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Background
Ischemic stroke is the third leading cause of death and
the first leading cause of long-term disability in the
world population. Although tissue type plasminogen ac-
tivator can be given during the three hours after a
stroke, this treatment can only be administered to a
small percentage of patients [1]. Overall, there is no
effective treatment to improve functional recovery in the
post-ischemic phase. The rehabilitation of patients
with stroke is difficult and slow. Thus, the therapeutic
strategy for post-stroke patients still remains under
investigation.
It is recognized that neurogenesis play an important
role in the rehabilitation after stroke in patients. The
process of neurogenesis involves cell proliferation, mi-
gration, and differentiation in the ischemic region of
brain [2], and is regulated by a series of signaling path-
ways. The transcription factor cAMP response element-
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binding protein (CREB) is associated with neuronal de-
velopment, synaptic plasticity, and regeneration and cell
survival in response to cerebral ischemia [3]. The
cAMP/PKA/CREB signal transduction pathway plays a
pivotal role in multiple aspects of neurogenesis [4].
Brain-derived neurotrophic factor (BDNF) regulates
multiple steps of neurogenesis, including proliferation,
migration, differentiation, and survival [5].
Huatuo Zaizao pill (HT), a pure natural preparation
derived from plants, is a traditional Chinese medicine
formulation marketed in China. HT was listed in the
pharmacopoeia of the People’s Republic of China Part I
(Pharmacopoeia Commission of the People’s Republic of
China, 1990). The pharmacopoeia of the People’s Repub-
lic of China Part I (Pharmacopoeia Commission of the
People’s Republic of China, 2015) demonstrates that HT
can be used to promote the rehabilitation after stroke.
Thrombosis is the common cause of ischemic stroke.
With the thrombosis test of both in vitro and in vivo,
HT inhibited platelet aggregation and thrombosis forma-
tion. Therefore, HT had a property to improve microcir-
culation disturbance and prevent cerebral thrombosis
[6]. Using a cerebral I/R rat model, Liu and colleagues
found that HT reduced the neurological deficit score
and infarct volume. HT had protective effects on neuron
and glial cells in the penumbra area [7]. Previous studies
also reported that HT was effective for improving neuro-
logical functions in stroke patients [8–10]. HT improved
the symptoms of hemiplegia and hemianesthesia in is-
chemic stroke patients by reducing the platelet aggrega-
tion and whole blood viscosity [11]. It reported that HT
promoted the functional recovery of cerebral ischemia
patients through decreasing the levels of endothelin,
thromboxane A2 [12]. Xia and colleagues had analyzed a
total of 10 randomized controlled trials involving 942 is-
chemic stroke cases. The meta-analysis revealed that HT
showed a superior efficacy in treating ischemic stroke
[13]. Another meta-analysis also showed that HT pro-
moted the functional recovery of ischemic stroke patients
[14]. In 2012, a phase IV, double blind, placebo-controlled,
randomized, multi-center study to evaluate the effi-
cacy of HT in improving of neural function in acute
ischemic stroke had been performed (Clinical Trials.
gov Identifier: NCT01758536). Despite the evidence
that HT is administered to promote the rehabilitation
in stroke patients, the mechanisms of pharmacological
action of HT are still unclear.
HT mainly consists of five Chinese herbs: Ligusticum
chuanxiong hort, Borneol, Evodia rutaecarpa (Juss.) Benth.,
Carthamus tinctorius L., and Angelica sinensis. Over the
past decades, an increasing amount of research data
showed that promoting neurogenesis is a viable therapeutic
method for the treatment of stroke [15, 16]. Here, we
hypothesize that HT promotes the rehabilitation of stroke
by elevating neurogenesis. In this study, whether HT could
promotes functional recovery and neurogenesis in a rat
model of cerebral I/R injury, and the potential molecular
mechanisms of these responses, such as signal transduction
pathway associated with BDNF, were investigated.
Methods
Drug
HT was provided by GuangZhou BaiYunShan QiXing
Pharmaceutical Co., LTD (Guangzhou China; batch
number: 13193). The dosage for adult patients is 8–16 g
(crude materials) per day. The information of quality
control about HT can be found in the pharmacopoeia of
the People’s Republic of China Part I (Pharmacopoeia
Commission of the People’s Republic of China, 2015).
The suspension of HT was prepared with 0.5% sodium
carboxymethyl cellulose (CMC-Na).
Animals
Male Sprague–Dawley rats weighing 260–280 g were
provided by Beijing HFK Bioscience Co., Ltd (Beijing,
China) 1 week prior to the experiment (Experimental
animal certificate number: SCXK [Beijing] 2009–0015).
Rats were maintained on a 12-h light/dark cycle with
free access to food and water. Animal treatment and
maintenance were carried out in accordance with Princi-
ples of Laboratory Animal Care (NIH Publication No. 85–
23, revised 1985) and according to the rules and ethics set
forth by the Ethical Committee of Yantai University. Ap-
proval for this study was granted with the registration
number: 16/ECYU-13 (dated: March 16, 2013).
Cerebral I/R model
Cerebral I/R model was carried out according to a previ-
ous method [17]. Briefly, rats were anesthetized with
chloral hydrate (300 mg/kg, intraperitoneal injection)
and placed in a supine position on a heated pad, with
body temperature maintained at 37 °C using a rectal
thermometer. A fish wire (Φ0.18 mm; Maitelifishing
tackle Co., Ltd, Zhejiang, China) rounded by heating it
near a flame (top diameter of 0.3 mm) was then intro-
duced into the internal carotid artery through a small
incision, and positioned approximately 18 mm from the
carotid bifurcation. The fish wire was withdrawn for
reperfusion 90 min later. Sham-operated group rats
received sham surgery in which an identical procedure
was followed but without the insertion of the fish wire.
Neurological assessment
A neurological examination was performed according to
Longa’s methods 24 h after I/R [18]. The criteria were as
follows: 0, no deficit; 1, failure to extend the left fore-
paw fully; 2, circling to the left; 3, falling to the left;
4, no spontaneous walking with a depressed level of
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consciousness. The rats with scores of 0 or 4 were
excluded from the study.
Grouping and treatment
According to Longa’s score, rats were randomly assigned
to five experimental groups with 12 animals in each
group: sham-operated group, model group, HT at dose
of 0.5 g/kg group, HT at dose of 1.0 g/kg group, and HT
at dose of 2.0 g/kg group. The selected dosages of HT
were based on our pilot study (Data not shown).
Twenty-four hours after I/R, rats in HT groups were
orally administered their respective dose of HT, once
daily for 7 days. The rats in the sham and model groups
were given 0.5% CMC-Na.
Behavioral testing
Animals were handled to reduce stress before behavioral
testing. All equipment, as well as the testing surface, was
cleaned with 75% ethanol and left to dry before each ani-
mal was tested. The assigned groups of the animals were
blinded to the investigator conducting and scoring the
behavioral tests. All tests were performed in a quiet and
dimly light room 7 days after HT treatment. Each test
was repeated twice and separated by at least 30 min.
The cylinder test assessed forelimb use asymmetry, and
was performed as previously described with minor
modifications [19]. Rats were placed inside a transpar-
ent glass cylinder (20 cm in diameter and 30 cm in
height; RWD Life Science Co., Ltd., Shenzhen, China).
A total of 20 movements were recorded during the test.
Forelimb asymmetry was then calculated using the
formula: 100 × (ipsilateral forelimb use + 1/2 both)/total
forelimb use. A beam-walking test was applied to assess
coordination and integration of motor movements as a
measure of functional recovery in I/R-injured rats [20].
Rats were trained for 2 days before I/R injury. The
apparatus consisted of a wooden beam (2.5 × 120 cm,
positioned at a height of 50 cm by two supporting legs).
A wooden box (30 cm × 30 cm × 30 cm) was set at
another side to motivate the animal to cross the beam.
The time taken to traverse the beam was recorded by a
stopwatch. The cut-off time was taken as 60 s. The
adhesive test was performed to assess the sensorimotor
deficit, as previously described [21]. Adhesive tape
(6 mm in diameter) was placed on the palmar surface
of the paw with equal pressure, and the rat was ob-
served in a cage. The time of the first contact of adhe-
sive tape was measured and recorded for each forelimb.
The rats were given a maximum of 2 min to perform
this task.
Immunofluorescence assay
The double labeling of 5-ethynyl-2-deoxyuridine (EdU)
and neuronal nuclear protein (NeuN) was performed.
EdU incorporation was detected using the Click-iT EdU
Alexa Fluor® Imaging Kit (Invitrogen Life Technologies,
Oregon, USA). Three rats in each group were injected
intraperitoneally with EdU (50 mg/kg; diluted in 0.9% sa-
line). Twenty-four hours later, serial coronal sections
from bregma −1.80 to −4.30 were selected for immuno-
fluorescent staining. Sections were incubated with the
primary polyclonal goat against NeuN antibody (1:500,
Santa Cruz Biotechnology, Santa Cruz, CA) for 30 min
at 37 °C. Sections were then incubated with the second-
ary anti-rabbit IgG, F(ab’) 2 Fragment (Alexa Fluor® 594
Conjugate) (Cell Signaling Technology, MA, USA) for
1 h at 37 °C. Brain sections were investigated using a
fluorescent microscope (Olympus IX83, Tokyo, Japan).
Images were acquired with an Image-Pro Plus 6.0 soft-
ware. The number of positive for EdU/NeuN within the
ipsilateral peri-infract cortex were counted using a
microscope (20 × objective). In all of the slices, five
fields of peri-infarct regions of cortex per brain sample
were quantified by an observer blinded to the experi-
mental treatment.
Real-time PCR (RT-PCR)
The peri-infarct regions of cortex of four rats in each
group were collected on day 3 and day 7 of HT treat-
ment. Total RNA was extracted from tissues by Trizol
Reagent (Invitrogen Life Technologies). Total RNA was
reversely transcribed to cDNA using the AMV First
Strand cDNA Synthesis Kit (Sangon Biotech, Shanghai,
China). PCR amplification was performed in 20 μL
containing 1 μL of each primer and 10 μL SybrGreen
RT-PCR Master Mix (Toyobo, Osaka, Japan). The ampli-
fication procedure was performed at 95 °C for 3 min
followed by 40 cycles of amplification reactions at 95 °C
for 15 s and 60 °C for 40 s. The primers used included
BDNF (185 bp): forward, 5′ TGGGGTTAGGAGAAGT
CAAGC 3′, reverse, 5′ TGTTTCACCCTTTCCACT
CCT 3′; β-actin (163 bp): forward, 5′ CGTAAAGAC
CTCTATGCCAACA 3′, reverse, 5′ AGCCACCAATC
CACACAGAG 3′. β-Actin cDNA was used as a control.
Relative expression between a given sample and a refer-
ence sample was calculated using the 2–ΔΔCt method [22].
Western blotting
The peri-infarct regions of cortex were lysed in RIPA
lysis buffer (50 mM Tris, 150 mM NaCl, 1% Triton X-
100, 1% sodium deoxycholate, 0.1% SDS) and centri-
fuged at 12,000 g for 20 min at 4 °C. Proteins were then
loaded (80 μg per lane) and subjected to 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis. The
membranes were incubated overnight at 4 °C with the
primary antibodies: rabbit anti-PKA (1:1000; Cell Signal-
ing Technology, MA, USA), rabbit anti-phospho-CREB
(Ser133) (1:1000; Cell Signaling Technology, MA, USA),
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rabbit anti-CREB (1:1000; Cell Signaling Technology,
MA, USA), or rabbit anti-BDNF (1:500, Santa Cruz
Biotechnology, Dallas, TX, USA). The membranes were
processed with the respective horseradish peroxidase-
labeled secondary antibody (1:2000; Beyotime Institute
of Biotechnology). Bands were visualized using the ECL
kit (Beyotime Institute of Biotechnology), and bands were
quantified using Image Quant LAS 4000 (GE Healthcare
Bio-Sciences AB, Tokyo, Japan). β-Actin (1:1000; Beyotime
Institute of Biotechnology) served as the loading control.
Statistical analysis
Data are presented as the mean ± SD and were analyzed
by one-way analysis of variance followed by the least sig-
nificant difference test. Values of p < 0.05 were consid-
ered statistically significant. The SPSS 17.0 Statistical
Software was used for the analyses.
Results
Effect of Huatuo Zaizao pill on functional recovery after
cerebral I/R in rats
In the cylinder test, animals in the sham group did not
show any paw preference during rearing. I/R injury led
to a motor deficit in the impaired forepaw, which was
indicated by a significant preference for the use of the
unimpaired forepaw compared with sham group (p <
0.01). HT administration significantly improved the
performance of I/R rats in the cylinder test (p < 0.05 or
p < 0.01) (Fig. 1a). Animals treated with HT for 7 days
spent a markedly longer time crossing the beam com-
pared with sham group (p < 0.01). The walking time in
the HT groups was significantly shorter than that of
the model group without HT treatment (p < 0.01)
(Fig. 1b). The functional recovery of sensorimotor im-
pairments was assessed as the time needed to contact
the adhesive tape by the impaired forepaw. Rats in the
model group significantly prolonged the contact time
compared with the sham group (p < 0.01). I/R rats with
HT treatment had a significantly improved perform-
ance (p < 0.01) (Fig. 1c).
Effect of Huatuo Zaizao pill on neurogenesis after
cerebral I/R in rats
The co-localization of EdU and NeuN was examined
after 7-day treatment in the peri-infarct regions of cortex
of rats. Few co-stained cells were observed in the sham
group. A higher number of co-stained cells were found
in the model group compared with the sham group
(p < 0.01). HT treatment significantly increased the
number of cells co-labeled with EdU and NeuN compared
with the model group (p < 0.05 or p < 0.01) (Fig. 2).
Effect of Huatuo Zaizao pill on the level of BDNF mRNA
in I/R rats
The level of BDNF mRNA in peri-infarct regions of cor-
tex was detected on day 3 and day 7 treatment. Com-
pared with model rats, the mRNA expression of BDNF
was significantly augmented in the peri-infarct regions
of cortex of rats treated with 1.0 or 2.0 g/kg HT for
3 days (p < 0.01). However, a 7-day HT treatment did
not significantly alter BDNF mRNA expression com-
pared with the model group (Fig. 3).
Effect of Huatuo Zaizao pill on the PKA, p-CREB/CREB,
and BDNF expressions in I/R rats
The protein expressions of PKA, CREB, p-CREB, and
BDNF in peri-infarct region of cortex were examined on
day 7 of HT treatment. Western blotting showed that I/
R injury markedly reduced the level of expression of
PKA compared with the sham group (p < 0.05). Com-
pared with model group, HT treatment significantly
increased PKA expression (p < 0.01). I/R injury re-
duced p-CREB compared with the sham group, and
HT significantly promoted p-CREB compared with the
model group (p < 0.05). I/R injury significantly reduced
BDNF expression compared with sham group (p < 0.05),
and HT treatment markedly increased BDNF compared
with model group (p < 0.01) (Fig. 4).
Discussion
In this study, the effects of HT on functional recovery in I/
R rats were investigated. Based on previous methodologies
Fig. 1 Effect of Huatuo Zaizao pill on functional recovery after 7-day cerebral I/R in rats. a Cylinder test. b Beam-walking test. c Adhesive
test. ##p < 0.01 vs. sham group; *p < 0.05, **p < 0.01 vs. model group
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for evaluating neurological function after brain injury [23],
the behavioral performance of HT in ischemic rats was
assessed by the cylinder test, beam-walking test, and adhe-
sive test. The results showed that a 7-day treatment with
HTattenuated the preference for the use of the unimpaired
forepaw in the cylinder test, reduced the walking time in
the beam-walking test, and decreased the contact time in
adhesive test. These findings demonstrated that HT could
promote functional recovery after cerebral I/R in rats.
Neurogenesis plays a key role in promoting functional
recovery after stroke [24]. Whether HT could promote
functional recovery by increasing neurogenesis in a rat
model of cerebral I/R injury is still unclear. The effects
of HT on neurogenesis were investigated via double
Fig. 2 Effect of Huatuo Zaizao pill on neurogenesis after 7-day cerebral I/R in rats. a EdU-positive cells (green) with NeuN-positive cells (red).
b Quantification of the number of cells with co-localized EdU and NeuN. ##p < 0.01 vs. sham group; *p < 0.05, **p < 0.01 vs. model group
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immunofluorescence staining. EdU incorporating into
cellular DNA was used to detect DNA synthesis during
the S phase of the cell cycle [25]. NeuN is a marker of
mature neurons. EdU labeled cells co-expressed NeuN
suggesting that newborn cells differentiate into neurons
after genesis [26]. The results of double staining of EdU
and NeuN showed a significant increase in the number
of newborn neurons in HT-treated animals. This result
indicates that HT may increase the neurogenesis,
thereby to promote functional recovery after stroke.
CREB is a transcriptional factor associated with neuro-
logical disease-related genes [27]. It is abundant in the
central nervous system and particularly in neurons.
CREB phosphorylation is implicated in both neuronal
plasticity and neurotrophin-mediated neuronal survival
[28]. PKA phosphorylates CREB and phosphorylated
CREB may then bind to the CRE element of the pro-
moter and consequently, promote the transcription of
BDNF [29]. Tanaka et al. have shown a rapid and
transient increase in CREB phosphorylation within the
ischemic core territory following cerebral ischemia. Fur-
thermore, p-CREB is decreased significantly following 12
and 24 h of cerebral I/R [30]. Heightened expression of
BDNF plays an important role in modulating neurogen-
esis after stroke [31]. There is a possible connection
between the PKA/CREB signal transduction pathway
and BDNF [32]. In this study, the effects of HT on PKA/
CREB and BDNF expression were explored in the peri-
infarct regions of cortex of rats. The results showed that
protein expression of PKA was significantly decreased
after cerebral I/R injury. HT treatment reversed this ef-
fect. Furthermore, in the peri-infarct regions of cortex,
the total protein level of CREB did not alter, but p-CREB
was found to be significantly reduced in the model
group. HT treatment could increase CREB phosphoryl-
ation, thus p-CREB/CREB was raised.
Gene expression levels can vary in different brain areas
after stroke and across the different stages of the ische-
mic cascade. Previous report showed there was a transi-
ent up-regulation of BDNF mRNA during the 24 h after
the ischemic insult [33]. It was also reported that an in-
crease in BDNF mRNA expression occurs between 1
and 3 days, returning to basal level 4 days after cerebral
ischemia [34]. However, this study found that BDNF was
down-regulated in ischemic brain tissue at 4 day after
cerebral I/R. We supposed the disparity may be due to
the difference of ischemic time and sampling area. In
consistent with Lee and colleagues, we found that BDNF
mRNA decreased significantly in the ischemic brain tis-
sues at 7 d after cerebral I/R, and that BDNF protein
showed a similar expression pattern to its mRNA [35].
Our results showed that the peri-infarct regions of cor-
tex in 3-day HT-treated rats revealed a higher BDNF
mRNA. No significant alterations in BDNF mRNA were
found between the HT group and the model group at
this time-point, while a 7-day treatment of HT increased
the protein levels of BDNF in the peri-infarct regions of
cortex. Protein production and maintenance requires a
series of processes. Therefore, proteins may not occur in
proportion to their relative mRNA levels [36]. Based on
previous reports and our current findings, it is reason-
able to suppose that HT treatment increased the mRNA
then protein level of BDNF through the activation of the
cAMP/PKA/CREB signal pathway.
Neurogenesis and angiogenesis after stroke are linked
together and coordinated. For instance, neuroblasts mi-
grate from the SVZ region to the ischemic area where
post-stroke angiogenesis occurs, and these neuroblasts
migrate closely with cerebral vessels. Many migrating
neuroblasts are found to localize specifically to blood
vessels in areas of active vascular sprouting and remod-
eling in the infarct boundary [37]. It is also reported that
neurogenesis and angiogenesis are coupled to enhance
Fig. 3 Effect of Huatuo Zaizao pill on the level of BDNF mRNA in
the peri-infarct regions of cortex in cerebral I/R rats. a The level of
BDNF mRNA on day 3 of HT treatment. b The level of BDNF mRNA
on day 7 of HT treatment. ##p < 0.01 vs. sham group; **p < 0.01 vs.
model group
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central nervous repair after ischemic stroke [38]. Al-
though our data show that HT promotes neurogenesis
in stroke rats, further studies are warranted to determine
the effects of HT on angiogenesis.
Conclusion
HT is a traditional Chinese medicine used for manage-
ment of stroke. This study distinctly demonstrated that
HT promoted behavioral recovery of rats with I/R
induced cerebral damage. Furthermore, HT enhanced
the expression of BDNF and increased the level of
neurogenesis in cerebral I/R animal. These findings may
elucidate the pharmacological basis of the action of HT
that help rehabilitate patients with stroke.
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